Looking beyond the spin of Big Pharma PR. But encouraging gossip. Come in and confide, you know you want to! “I’ll publish right or wrong. Fools are my theme, let satire be my song.”
Email: jackfriday2011(at)hotmail.co.uk
Saturday, July 25, 2009
IMS to decimate
IMS Health has reported a 19% drop in Q2 profit to $62.9m from $77.7m a year earlier.
Accordingly, the firm is planning to shed a total of 850 staff, or 11% of its global workforce; 500 jobs in Europe and 170 positions will be made redundant in the US.
No comments:
Post a Comment